Objectives: Studies of major amputation after initial minor amputation are limited with rates of subsequent major amputation ranging from 14% to 34% with a limited understanding for associated comorbidities and time to subsequent amputation. We sought to determine major amputation rates for patients that undergo initial minor amputation and determine which factors are associated with limb preservation with open vs endovascular treatment.
who underwent revascularization, there was no difference in risk of subsequent major amputation for patients that underwent initial open revascularization vs endovascular therapy (hazard ratio, 0.92; 95% confidence interval, 0.92-1.04). There was also no difference in time to subsequent major amputation between open and endovascular treatment (9.8 vs 8.7 months; P ¼ S). In multivariable analysis, patients who could be treated completely in the outpatient setting were less likely to undergo amputation (hazard ratio, 0.7; 95% confidence interval, 0.5-0.99) compared with those who required hospitalization or presented to the emergency room.
Conclusions: Patients with ischemic ulcers and diabetes are at the highest risk for subsequent major and minor amputation, with most occurring within a year of the initial minor amputation. Initial endovascular treatment did not increase the risk of subsequent major amputation compared with open and there was no difference in time to amputation indicating the endovascular first approach may be reasonable for patients with critical limb ischemia. Objectives: The ideal result of infrainguinal bypass (IBP) with in-line flow to the foot should be a normal hemodynamic result indicated by a palpable pulse/normal ankle-brachial index (ABI). The results of intervention can vary depending on inflow and outflow of the bypass and the quality and type of conduit chosen. The object of this study is to identify outcome depending on the hemodynamic result after IBP.
Methods: National Vascular Quality Initiative (VQI) data from 2003 to 2017 were queried to identify patients with CLI and claudication treated with IBP with primary patency at 1 year. The outcome of interest was maintenance of ABI between 0.9 and 1.3 (normal ABI) at 1 year. Exclusions included patients with noncompressible tibial vessels, those without postoperative ABI and 1 year follow-up, and those with prior ipsilateral infrainguinal endovascular intervention or IBP. Of a total of 37,970 patients, 1519 met our selection criteria. Cohorts perfusion grade were: ABIs 0 to 0.5, (n ¼ 206), ABIs 0.5 to 0.9 (n ¼ 665), and ABIs 0.9 to 1.3 (n ¼ 648; Table I ). Demographics and procedural factors were evaluated for predictors of failure to maintain unassisted normal ABI at 1 year using multivariable logistic regression. Stepwise regression was used for variables with P < .2 from c 2 or t test analysis.
Results: Of the 648 patients with a normal ABI at discharge, 79.6% maintained a normal ABI at one year follow-up, and 2 patients underwent major amputation. When discharged with an ABI of <0.9, 54.7% had a subsequent ABI measured at >0.9 at the 1-year follow-up and a total of six major amputations occurred. In patients with a normal ABI at discharge, multivariable analysis demonstrated that any history of nonindex limb peripheral vascular intervention, coronary artery disease, concomitant endarterectomy, diabetes, pedal bypass target, postoperative congestive heart failure, or sequential graft were predictive of a drop in ABI at 1 year to <0.9. (Table II) . The discharge ABI 0.5 to 0.9 cohort multivariable analysis showed that hypertension, female gender, postoperative myocardial infarction, and nonwhite race were predictive of poor hemodynamic result; use of vein conduit and preop ABI grade were protective of a maintained ABI at the 1-year follow-up (Table II) .
Conclusions: These results suggest that patients with a normal ABI immediately after bypass have a high likelihood of maintaining a normal hemodynamic response at one year, irrespective of conduit choice. However, conduit type, among other factors, becomes important when postoperative perfusion results are not optimal. Objectives: Patients undergoing bypass for lower extremity ischemia (LEI) require intensive health care resource use. Prior study has demonstrated that these patients frequently require rehab or skilled nursing homes following surgical intervention, yet little study has evaluated whether it is possible to predict non-home discharge (NHD) in this patient population. Early preoperative identification of those at high risk for NHD may help improve preoperative counselling and hospital efficiency in providing appropriate resources to those who need it. This study sought to predict NHD using preoperative risk-factors in patients undergoing bypass for LEI using a novel risk score.
Methods: The Vascular Study Group of New England (VSGNE) was queried for patients undergoing suprainguinal or infrainguinal bypass for LEI from years 2003 to 2017. Cases were excluded if they were not admitted from home, if they were bedridden, or died during the index admission. The primary end point was NHD. The data was split twothirds for model derivation and one-third for validation. Factors were evaluated for model inclusion by virtue of meeting P < .1 on bivariate analysis. A parsimonious manual stepwise binary logistic regression for NHD was performed maximizing the C-statistic while maintaining model simplicity for clinical use. A risk score was then developed using beta coefficients and applied to the dataset. The risk score performance was assessed in both the developmental and validation datasets.
Results: Overall 10,145 cases were included with an NHD rate of 26.4% (n ¼ 2,676). Mean age was 66 years (range, 41-90years). NHD patients were older (72 years vs 64 years; P < .01) more frequently male (57.2% vs 42.8%, P < .01), non-white (16.1% vs 9.9%, P < .01), and had tissue loss (54.2% vs 23.0%, P < .01), anemia (16.0% vs 5.3%, P < .01), severe cardiac comorbidity (21.8% vs 10.5%, P < .01), and insulin dependent diabetes (IDDM; 33.3% vs 18.2%, P < .01). On multivariable analysis factors associated with NHD included age, non-white, tissue-loss, cardiac comorbidity partial ambulatory deficit and IDDM (Table) . The C-statistic was 0.78 in the derivation group and 0.79 in the validation group with Hosmer-Lemeshow P > .999. The risk score ranged from 0 to 18 with a mean score of 4 
